Hematology and Hemotherapy
The close relationship between the Cima and the Clinic allows patients to benefit from new scientific advances, facilitating excellence in patient care and research.
The Clinic's Hematology Service, composed of specialists of renowned national and international prestige, has integrated molecular diagnostic techniques and the use of new personalised treatments in its care activity, allowing a more precise and rapid diagnosis of haematological diseases.
The joint work of the medical and research personnel facilitates the development and application of the new treatments and, at the same time, the precise evaluation of the result of the treatments.
We are experts in the development of treatments based on the use of Cellular Therapy and those that include the transplantation of hemapoietic progenitors, adoptive cellular immunotherapies such as CAR-T cells, dendritic cell vaccines, or activated lymphocytes for the treatment of infections. These treatments are developed jointly with the Cellular Therapy Area.
Currently, the Hematology Service has received accreditation for the administration of CAR-T drugs approved by the Spanish and European regulatory agencies (Kymriah, INN-tisagenlecleucel, Yescarta, INN-axicabtagene ciloleucel and Tecartus) and is in the process of accrediting the new CAR-T drugs for the treatment of multiple myeloma.
In addition, the Advanced Therapies Unit of the Hematology Service and Cell Therapy Area has been accredited according to FACT-JACIE international standards for the performance of hematopoietic progenitor transplantation (HPT) in adults; and the collection, processing and administration of hematopoietic cell therapy products and immunoeffector cells.
Having led some of the clinical trials that have enabled the approval of new drugs such as daratumumab, we are an international reference centre in the field of lymphomas, myeloid neoplasms and, in particular, myelomas and monoclonal gammapathies.
We are experts in the diagnosis and treatment of haemorrhagic and thrombotic problems, using molecular diagnostic tools to study thrombophilic states and the application of new oral anticoagulants, as well as a personalised approach to patients with thrombosis and cancer.
Do you need a remote second opinion?
Our professionals will provide you with a medical evaluation without you having to leave your home.
Learn more about our clinical trials
New therapeutic possibilities and advances for our patients
Comprehensive medical care for our patients
IN NAVARRE AND MADRID
DISEASES
TREATMENTS
-
Liquid biopsy
-
Flow cytometry
-
Next Generation Sequencing (NGS)
-
Purification and quantification and characterization of nucleic acids
-
Capillary sequencing and STR identification of cell lines
TREATMENTS
-
Monoclonal antibodies
-
New drugs
-
Transplantation of haematopoietic progenitors
-
Treatment of thrombosis
-
Tumour vaccines
-
Cell therapy treatments
-
CAR-T cell therapy
Do you need to request a consultation with one of our specialists?
Laboratories
The Hematology and Hemotherapy Service has different interconnected laboratories in order to offer a rapid cytological and molecular diagnosis of leukaemias, lymphomas and lymphoproliferative syndromes:
- Cytogenetics and Molecular Genetics Laboratory.
- Cytomorphology Laboratory.
- Haemostasis and Coagulation Laboratory.
The Blood Bank
The Blood Bank at the Clínica Universidad de Navarra is equipped with the most modern facilities for the storage of blood products necessary for the treatment of patients.
Being accredited by the Transfusion Accreditation Committee (CAT) of the SEHH and the SETS, it ensures the quality of the haemotherapy administered at the Clínica Universidad de Navarra.
The Day hospital
The Day Hospital is a specialised unit with highly qualified personnel who provide patients and their families with information about the procedure and care to be followed, as well as continuous contact at home.
One of the goals of the Day Hospital is to provide efficient and comprehensive medical care to the patient.
A multidisciplinary team of renowned prestige being at the forefront
AT THE FOREFRONT
Advanced Therapy Unit
The Advanced Therapies Unit of Clínica Universidad de Navarra has been established in order to deal exclusively with cellular therapies against cancer and other diseases of the immune system, favouring their administration and seeking to increase the safety of these treatments.
A multidisciplinary team of highly specialised nurses together with physicians from all the specialities involved in the approach to those treatments that depend on advanced therapy drugs and immunotherapy
PERSONALISED TREATMENT
Therapeutic advances
Our main goal is to provide our patients with a complete information, based on precise molecular diagnosis and therapeutic guidance including the possibility of receiving state-of-the-art treatments, in addition to new promising drugs in the context of clinical trials and human support from our medical and nursing staff.
GMP Cell Therapy Laboratory
This laboratory produces advanced therapy medicines under good manufacturing practices and is authorised by the Spanish Agency for Medicines and Health Products.
Specialized Nursing
Its work is focused on the monitoring of the therapeutic process, the palliation of possible adverse symptoms caused by the medication and the prevention of possible complications.
Excellence in research
The Clínica Universidad de Navarra is a pioneer in cancer research and in addressing other diseases related to the immune system.
Why choose the Clinic?
- Multidisciplinary team of international reference.
- Highly specialised nursing team.
- First GMP Cell Therapy Laboratory accredited in a hospital within the National Health System.
Our team of professionals
An international reference laboratory
Precision medicine
CIMA LAB Diagnostics
The Haematology Service includes the morphological diagnosis and general haematology laboratories, the coagulation laboratory and the blood bank, all located in the same centre, which work together with CIMA LAB Diagnostics, which has the Cytometry and Genomics Units, which use the most up-to-date techniques for molecular diagnosis.
CIMA LAB is currently an international reference centre in the field of haematological diseases diagnostic.
We help our patients to overcome their stories
Their testimonies encourage us to continue improving our services
Sven
Multiple Myeloma
"The humane treatment I have received has always been outstanding.
Before the illness I lived too much in the future and less in the present, but we must change: live the present and still have many dreams to fulfill.
Olga
Myelodysplastic Syndrome
"I never had any feeling of sadness, as far as I can remember. I didn't let it make me sad.
I am by nature an optimist, learning to be patient. I don't think about the future, the best thing for anyone is to enjoy the present.
Jon
Leukemia
"The disease was very serious but it had a cure. My life changed a lot during those years.
I had a bone marrow transplant and as soon as I recovered, I started doing what I love: going to the mountains, traveling, skiing, climbing, etc.
Amelia
Multiple Myeloma
"This clinical trial is an opportunity for me to live. It is a privilege to be able to access this novel treatment for my multiple myeloma.
I am terribly excited, I have a great desire to live because I believe it will be an important advance for me.
Francisco
Thrombosis of genetic origin
"I had several thromboses in a row in my legs. They studied possible genetic causes for these thromboses.
My daily life has not been affected at all. Life is exactly the same. I recommend that older people try to exercise.
